Search

Search Constraints

You searched for: Author/Creator Fritsche, Jens

Search Results

1. 293 Resultsof the first-in-human clinical trial with personalized multi-target adoptive cell therapy (ACTolog IMA101). (9th November 2020)

2. Front Cover: Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection. Issue 12 (27th June 2018)

3. IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial. Issue 11 (November 2016)

4. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Issue 1 (13th October 2017)

5. Translating Immunopeptidomics to Immunotherapy‐Decision‐Making for Patient and Personalized Target Selection. Issue 12 (10th April 2018)